JP Patent

JP2022517396A — Ｅｇｆｒ阻害剤の塩、結晶形及びその製造方法

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2022-03-08 · 4y expired

What this patent protects

本願は、ＥＧＦＲ阻害剤の塩、その結晶形、製造方法、及び非小細胞肺がんの治療薬物を製造するための前記塩及び結晶形の用途を提供し、前記塩は式（ＩＩ）に示す構造を有する。【化１】【選択図】図１

USPTO Abstract

本願は、ＥＧＦＲ阻害剤の塩、その結晶形、製造方法、及び非小細胞肺がんの治療薬物を製造するための前記塩及び結晶形の用途を提供し、前記塩は式（ＩＩ）に示す構造を有する。【化１】【選択図】図１

Drugs covered by this patent

sonidegib-phosphate (SONIDEGIB PHOSPHATE)

Patent Metadata

Patent number: JP2022517396A
Jurisdiction: JP
Classification: —
Expires: 2022-03-08
Drug substance claim: No
Drug product claim: No
Assignee: Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.